Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson’s Disease, recent trial suggests Post author: Post published:December 5, 2023 Post category:uncategorized A safe and feasible treatment option for reducing the motor signs of Parkinson’s disease. You Might Also Like Single-image 3D modeling of the colon can enable rapid disease diagnosis June 25, 2024 Bruker advances whole-organism 3D imaging with enhanced tissue-clearing workflows September 10, 2026 DNA methylation variability may improve precision cancer treatment strategies May 24, 2026